Pharmaceuticals & Therapeutics

Alberta is launching a controversial private healthcare option, promising efficiency. Critics warn it's a two-tier system that will let the rich jump the queue.

A new partnership between Pirche and Natera promises to connect pre-transplant risk analysis with post-transplant monitoring, ushering in an era of truly personalized care.

Ottawa's new asylum regulations promise speed and order, but critics warn of eroded protections. A deep dive into the strategy behind the reforms.

For Northern Nevada homeowners, a failing water heater is more than an inconvenience; it's a critical investment decision influenced by harsh local conditions.

Dr. Ruth J. Simmons' tribute to her sister at Texas Southern University is more than a donation; it's a strategic model for tackling deep-seated health disparities.

A new index reveals pharma's $8B ad spend fails to buy AI visibility. Eli Lilly and Novo Nordisk lead as AI follows patient research, not TV spots.

A looming federal announcement signals a major push for nuclear energy. This isn't just about climate goals; it's a commercialization roadmap for a new era.

A major partnership in Michigan and Ohio's ENT sector signals a growing trend: private equity-backed groups are reshaping independent medical practices.

For its 75th anniversary, the iconic rotisserie chain is partnering with pet retailer Mondou, tapping into the booming pet humanization market.

As Québec's population ages, a major healthcare union launches a campaign to confront systemic failures in senior care, challenging government strategy.

With a seasoned regulatory expert at the helm, Arletta Pharma is betting on its dual-action therapy, Lybrido, to transform the underserved FSIAD market.

A strategic pharma alliance scores a major win in Japan's lucrative neurology market, signaling a new competitive front and hope for thousands of patients.

Arverne CEO Pierre Brossollet's move to increase his stake is more than a vote of confidence; it's a strategic key unlocking a €70M investment.

Holcim's major acquisition of Xella signals a seismic shift in construction, betting big on sustainability. We explore the ripple effects of this deal.

A Las Vegas clinic offers a specialized program for first responders battling trauma and addiction. But does it address the systemic crisis facing our heroes?

Align Technology names Exact Sciences veteran Kevin Conroy its next Chairman, a strategic move signaling a new chapter of growth and innovation in digital dentistry.

A new AI tool scores meals on insulin impact, not calories. Can this data-driven approach disrupt the wellness market where others have stalled?

Brighton Marine's rebrand is more than a name change. It’s a calculated pivot to a self-sustaining social enterprise model where housing and healthcare are one.

With its Costco debut, FØRTE isn't just selling a protein bar; it's selling a solution to a market paradox. But can it disrupt the frozen aisle?

A small N.C. dispensary just outranked California's cannabis elite. Their secret? Redefining quality in a hazy market and proving craft can scale.